In particular, eEF1A2 levels resulted significantly increased in all prostate cancer cell lines with the highest levels detected in LNCaP (LNCaP, P=0.000005; DU-145, P=0.000001; and PC-3, P=0.0000007 vs PZHPV-7). The gene discussed is EEF1A2; the disease is prostate carcinoma.